OECD 50th Anniversary Conference, Paris, 22 June 2011.
This biotechnology global forum, "Delivering Global Promise Through the Life Sciences" underlined how the latest social science research into genomics science can help inform key global economic and policy decisions.
The OECD Employment, Labour and Social Affairs Directorate has launched in September 2008 a series of seminars open to both external and internal speakers. It is intended to be an informal forum for discussion of policy-oriented empirical research work among policy-makers, academics and OECD staff.
For many of today’s new biomedical innovations, the distinctions between different forms of medical products such as drugs, diagnostics and devices no longer apply. Biomedicine also tends to realize its potential today through process innovation, even more than product innovation.
The key goal of the current work is to identify further means (e.g. international guidelines, policy recommendations) to implement the 2004 OECD Science and Technology Ministers mandate on “Biotechnology for Sustainable Growth and Development” .
Workshop discussions were structured around a set of issues papers – one for each of the sessions. The workshop was set up as a working roundtable discussion. 50 participants familiar with data sources for industrial biotechnology attended the workshop.
The workshop discussed existing sector, national, or international approaches for assessment of sustainability of bio-based products, such as bio-based chemicals, bio-based plastics, enzymes, bio-based materials, and biofuels.
Synthetic biology is a transformative set of technologies which offer great opportunities for the construction of bioengineered parts, devices and microorganisms.
A High-Level Forum on Sickness, Disability and Work: Addressing Policy Challenges in OECD Countries will be held in Stockholm, Sweden on 14-15 May 2009.
The impact of biotechnologies on medical research is intensifying. Because of new highly performing technologies, we are better able to understand and explore disease and drug mechanisms, which in turn could lead to major changes in the approach of patient care.